|
Neonatal Intensive Care Drug Manual
|
bet | 81/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
Pharmacokinetics
Preterm neonates have reduced azithromycin clearance and increased volume of distribution compared to older children. The estimated half-life is approximately 58 hours for a typical 1 kg neonate. Once administered, very little of azithromycin resides in the plasma and the vast majority of azithromycin accumulates intracellularly leading to a prolonged elimination t1/2 and extended mean residence time (MRT). These characteristics favour administering higher dosage regimens of azithromycin. For effective Ureaplasma eradication, the plasma concentration of free unbound azithromycin must be maintained above the minimum inhibitory concentration that is required to inhibit 50% (MIC50) of Ureaplasma. Multiple dose administration of 10 mg/kg/day for 3 days azithromycin is inadequate to maintain azithromycin plasma concentrations above the MIC50. On the other hand, a dosage regimen of 20 mg/kg/day for 3 days would be sufficient to maintain azithromycin plasma concentration above the MIC50.16
Azithromycin (AZM) in fine granules was studied by Tajima T, et al 1997, for its pharmacokinetics and clinical efficacy in eight child patients with ages between 1 month and 8 years. AZM was administered to the patients once a day at a dose of 10 mg/kg for 3 days. The clinical efficacy of AZM in 8 patients with microbial infections (pneumonia in one, Mycoplasma pneumonia in two, acute tonsillitis in one, pertussis in one, Campylobacter enteritis in one, infectious enteritis in one, Salmonella enteritis in one) were evaluated as "excellent" in five cases, "good" in two and "not evaluable" in one. As for the microbial efficacy, isolated strains were eradicated in 2 out of 3 patients. No adverse reaction was found except for one case with abnormal laboratory change, a mildly increased ALT value. Plasma samples were collected from 3 cases. The elimination half-life of AZM was 45.8 hours. AUC0-∞was 12.6 microgram.h/mL. Urine sample was collected from one. AZM concentration in urine was 35.0 microgram/mL during a period between 48 and 72 hours after the start of treatment.18
|
|
| |